Articles from BIOTECH Patent News (February 1, 2006)

Title	Author	Type	Words
2ME2 patent strengthens EntreMed's position in cancer and non-oncology diseases.			534
Abaxis licenses of lyophilization technology to bioMerieux.			318
Beckman Instruments obtains United States patent.			131
Braintree in-licenses global rights to oncology drug platform.			778
CEL-SCI receives United States patent for use of peptide vaccine technology for autoimmune conditions and allergies.			801
CytRx provides update on RNAi-based drug discovery programs - progress made toward developing medicines to treat obesity and type 2 diabetes.			888
DiagnoCure granted patent for PCA3.			454
EMD Lexigen obtains United States patent.			109
GenoMed awarded second patent for avoiding dialysis in acute kidney failure.			284
HemoCue prevails in patent infringement suit.			355
Johns Hopkins obtains United States patent.		Brief article	126
Johns Hopkins obtains United States patent.		Brief article	87
Lilly and Biosite to collaborate on clinical trial using sepsis therapy.			734
McMichael, et al. obtains United States patent.		Brief article	106
Monsanto and University of California resolve dispute over technology used to produce bovine somatotropin for dairy cows.			330
Pharmacopeia and Neurocrine expand drug discovery and development collaboration.			609
Rigel granted patents in immunology, virology and oncology.			518
Senetek strengthens skincare and dermatological pipeline by agreement Athens University.			773
Signet announces the availability of monoclonal antibodies EGFR, clone F4 and VEGF, clone VG-1.			251
Studies validate test for Lp-PLA2, a cardiovascular-specific biomarker.			213
TissueGene obtains United States patent.			105
Vasogen Ireland obtains United States patent.		Brief article	115